Gene · 246100
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. | Cancers (Basel) | 2024 | 38275910 | PubTator, text mining | PubMed |
| Lymph Node-Targeted Vaccine Boosting of TCR T-cell Therapy Enhances Antitumor Function and Eradicates Solid Tumors. | Cancer Immunol Res | 2024 | 38270373 | PubTator, text mining | PubMed |
| Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. | Int J Mol Sci | 2024 | 38256268 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment. | Biomedicines | 2024 | 38255228 | PubTator, text mining | PubMed |
| Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells. | Biomedicines | 2024 | 38255224 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings. | Cancers (Basel) | 2024 | 38254805 | PubTator, text mining | PubMed |
| EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma. | Cancer Biomark | 2024 | 38250760 | PubTator, text mining | PubMed |
| Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches. | J Pers Med | 2024 | 38248769 | PubTator, text mining | PubMed |
| Advanced nano-based strategies for mRNA tumor vaccine. | Acta Pharm Sin B | 2024 | 38239240 | PubTator, text mining | PubMed |
| Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. | NPJ Vaccines | 2024 | 38238340 | PubTator, text mining | PubMed |
| BTLA biology in cancer: from bench discoveries to clinical potentials. | Biomark Res | 2024 | 38233898 | PubTator, text mining | PubMed |
| CAR-T cell manufacturing: Major process parameters and next-generation strategies. | J Exp Med | 2024 | 38226974 | PubTator, text mining | PubMed |
| Harnessing natural killer cell effector function against cancer. | Immunother Adv | 2024 | 38223411 | PubTator, text mining | PubMed |
| Cancer vaccines: from an immunology perspective. | Immunother Adv | 2024 | 38223410 | PubTator, text mining | PubMed |
| Cancer vaccines in the clinic. | Bioeng Transl Med | 2024 | 38193112 | PubTator, text mining | PubMed |
| Vaccines: a promising therapy for myelodysplastic syndrome. | J Hematol Oncol | 2024 | 38191498 | PubTator, text mining | PubMed |
| FTHL17, PRM2, CABYR, CPXCR1, ADAM29, and CABS1 are highly expressed in colon cancer patients and are regulated in vitro by epigenetic alterations. | Heliyon | 2024 | 38187237 | PubTator, text mining | PubMed |
| MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer. | Aging (Albany NY) | 2024 | 38180746 | PubTator, text mining | PubMed |
| Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. | Theranostics | 2024 | 38169577 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246100/papers?page=9